Assignee
CHASE THERAPEUTICS CORP
US·7 granted patents·11 pending applications·13 citations·filing 2018–2022
Top patents by PatentIndex Score
18 records- 0189US11160809B2NK1-antagonist combination and method for treating synucleinopathiesCHASE THERAPEUTICS CORP·Filed 2018·Granted Nov 2, 2021·4 cites·23 claims
- 0287US11266633B2NK-1 antagonist compositions and methods for use in treating depressionCHASE THERAPEUTICS CORP·Filed 2018·Granted Mar 8, 2022·5 cites·10 claims
- 0384US11547700B2Compositions and methods for treating synucleinopathiesCHASE THERAPEUTICS CORP·Filed 2020·Granted Jan 10, 2023·1 cites·11 claims
- 0479US10799484B2Compositions and methods for treating synucleinopathiesCHASE THERAPEUTICS CORP·Filed 2018·Granted Oct 13, 2020·2 cites·17 claims
- 0577US11813248B2NK-1 antagonist compositions and methods for use in treating depressionCHASE THERAPEUTICS CORP·Filed 2022·Granted Nov 14, 2023·0 cites·5 claims
- 0675US11813247B2NK-1 antagonist compositions and methods for use in treating depressionCHASE THERAPEUTICS CORP·Filed 2022·Granted Nov 14, 2023·0 cites·6 claims
- 0773US11318122B2Pharmaceutical combination and its use for treating synucleinopathtiesCHASE THERAPEUTICS CORP·Filed 2018·Granted May 3, 2022·1 cites·7 claims
- 0859US2025329454A1Diagnostic indices for neurodegenerative conditionsCHASE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 0955US2020375957A1Compositions and method for treating depressionCHASE THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1054US2022000854A1Domperidone antineurodegenerative combinations and useCHASE THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1154US2022214360A1Alpha-synuclein assaysCHASE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1253US2021393595A1Anti-neurodegenerative combinations and use for treatment of neurodegenerative diseasesCHASE THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1353US2023349906A1Kinases as biomarkers for neurodegenerative conditionsCHASE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1448US2020113899A1Statin compositions and methods for use in treating synucleinopathiesCHASE THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1547US2020400687A1Methods for developing pharmaceuticals for treating neurodegenerative conditionsCHASE THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1646US2022071976A1Domperidone compositions and methods for treating depressionCHASE THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1746US2021338652A1Composition and use for the treatment of parkinson's disease and related disordersCHASE THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1842US2020138792A1Pharmaceutical combinations of zonisamide and pramipexole, and related methods, for treating synucleinopathiesCHASE THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CHASE THERAPEUTICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →